Product Images Janumet XR

The text provides information about a medication called Janumet XR, which is a tablet that contains sitagliptin and metformin HCl in extended-release form. The tablets are dispensed with a Medication Guide for each patient. The tablets contain 50mg of sitagliptin and 500mg of metformin hydrochloride extended-release. The dosage and storage information are also provided. Therefore, it can be said that the given text provides a brief description of Janumet XR, including its pharmacological information, dosage, and storage instructions with the storage temperature range.*

Janumet' XR is a medication in tablet form containing sitagliptin and metformin HCl (extended-release) in a 50 mg/1,000 mg strength. The National Drug Code (NDC) for this medication is 0006-0080-61 and the accompanying medication guide should be given to each patient receiving the medication. The tablets can be identified by the imprint of "6425" which is a combination of sitagliptin phosphate (50 mg) and metformin hydrochloride (1000 mg).*

Janumet'XR is a medication used in the treatment of type 2 diabetes. It is a combination of sitagliptin and metformin hydrochloride extended-release tablets. Each tablet contains 128.5mg of sitagliptin phosphate and 1000 mg of metformin hydrochloride. It should be taken once a day in the evening. The medication guide should be dispensed to each patient. The tablets come in a 30 count bottle and should be stored at a temperature between 15-30°C. The manufacturer of Janumet'XR is Merck & Co., Inc. Dosage information can be found on the label or by contacting a health professional.*